• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非靶向质谱脂质组学鉴定血清神经酰胺与血浆胆固醇之间的相关性。

Untargeted Mass Spectrometry Lipidomics identifies correlation between serum sphingomyelins and plasma cholesterol.

机构信息

Lebanese American University, School of Medicine, Beirut, Lebanon.

University Paris Descartes, 15 rue de l'Ecole de Médecine, 75006, Paris, France.

出版信息

Lipids Health Dis. 2019 Feb 2;18(1):38. doi: 10.1186/s12944-018-0948-5.

DOI:10.1186/s12944-018-0948-5
PMID:30711004
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6359757/
Abstract

BACKGROUND

Lipoproteins are major players in the development and progression of atherosclerotic plaques leading to coronary stenosis and myocardial infarction. Epidemiological, genetic and experimental observations have implicated the association of sphingolipids and intermediates of sphingolipid synthesis in atherosclerosis. We aimed to investigate relationships between quantitative changes in serum sphingolipids, the regulation of the metabolism of lipoproteins (LDL, HDL), and endophenotypes of coronary artery disease (CAD).

METHODS

We carried out untargeted liquid chromatography - mass spectrometry (UPLC-MS) lipidomics of serum samples of subjects belonging to a cross-sectional study and recruited on the basis of absence or presence of angiographically-defined CAD, and extensively characterized for clinical and biochemical phenotypes.

RESULTS

Among the 2998 spectral features detected in the serum samples, 1328 metabolic features were significantly correlated with at least one of the clinical or biochemical phenotypes measured in the cohort. We found evidence of significant associations between 34 metabolite signals, corresponding to a set of sphingomyelins, and serum HDL cholesterol. Many of these metabolite associations were also observed with serum LDL and total cholesterol levels but not as much with serum triglycerides.

CONCLUSION

Among patients with CAD, sphingolipids in the form of sphingomyelins are directly correlated with serum levels of lipoproteins and total cholesterol. Results from this study support the fundamental role of sphingolipids in modulating lipid serum levels, highlighting the importance to identify novel targets in the sphingolipid metabolic pathway for anti-atherogenic therapies.

摘要

背景

脂蛋白是导致冠状动脉狭窄和心肌梗死的动脉粥样硬化斑块发展和进展的主要参与者。流行病学、遗传学和实验观察表明,鞘脂和鞘脂合成中间产物与动脉粥样硬化有关。我们旨在研究血清鞘脂的定量变化与脂蛋白(LDL、HDL)代谢的调节以及冠状动脉疾病(CAD)的内表型之间的关系。

方法

我们对属于横断面研究的受试者的血清样本进行了非靶向液相色谱-质谱(UPLC-MS)脂质组学分析,并根据是否存在血管造影定义的 CAD 进行招募,并对临床和生化表型进行了广泛的特征描述。

结果

在血清样本中检测到的 2998 个光谱特征中,有 1328 个代谢特征与队列中测量的至少一种临床或生化表型显著相关。我们发现,34 种代谢物信号(对应一组鞘磷脂)与血清 HDL 胆固醇之间存在显著关联。这些代谢物关联中的许多也与血清 LDL 和总胆固醇水平有关,但与血清甘油三酯水平的关联并不多。

结论

在 CAD 患者中,鞘磷脂以鞘磷脂的形式与脂蛋白和总胆固醇的血清水平直接相关。这项研究的结果支持鞘脂在调节血脂水平方面的基本作用,突出了确定鞘脂代谢途径中新的治疗靶点对抗动脉粥样硬化治疗的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/858c/6359757/ca0e38814e30/12944_2018_948_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/858c/6359757/20c1bb5c15e0/12944_2018_948_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/858c/6359757/ca0e38814e30/12944_2018_948_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/858c/6359757/20c1bb5c15e0/12944_2018_948_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/858c/6359757/ca0e38814e30/12944_2018_948_Fig2_HTML.jpg

相似文献

1
Untargeted Mass Spectrometry Lipidomics identifies correlation between serum sphingomyelins and plasma cholesterol.非靶向质谱脂质组学鉴定血清神经酰胺与血浆胆固醇之间的相关性。
Lipids Health Dis. 2019 Feb 2;18(1):38. doi: 10.1186/s12944-018-0948-5.
2
Lipidomic analysis of plasma lipoprotein fractions in myocardial infarction-prone rabbits.易患心肌梗死兔血浆脂蛋白组分的脂质组学分析。
J Biosci Bioeng. 2015 Oct;120(4):476-82. doi: 10.1016/j.jbiosc.2015.02.015. Epub 2015 Jul 8.
3
Atherogenic lipoprotein profile in families with and without history of early myocardial infarction.有和没有早期心肌梗死病史的家族中的致动脉粥样硬化脂蛋白谱。
Physiol Res. 2001;50(1):1-8.
4
Plasmalogens of high-density lipoproteins (HDL) are associated with coronary artery disease and anti-apoptotic activity of HDL.高密度脂蛋白(HDL)中的血浆脂类与冠状动脉疾病以及 HDL 的抗细胞凋亡活性有关。
Atherosclerosis. 2015 Aug;241(2):539-46. doi: 10.1016/j.atherosclerosis.2015.05.037. Epub 2015 Jun 9.
5
HDL-cholesterol concentration and severity of coronary atherosclerosis determined by cine-angiography.高密度脂蛋白胆固醇浓度与经血管造影术测定的冠状动脉粥样硬化严重程度。
Artery. 1980;8(2):101-12.
6
Significant abnormalities of the HDL phosphosphingolipidome in type 1 diabetes despite normal HDL cholesterol concentration.1 型糖尿病患者尽管 HDL 胆固醇浓度正常,但 HDL 磷磷脂组显著异常。
Atherosclerosis. 2015 Aug;241(2):752-60. doi: 10.1016/j.atherosclerosis.2015.06.040. Epub 2015 Jun 29.
7
On-line miniaturized asymmetrical flow field-flow fractionation-electrospray ionization-tandem mass spectrometry with selected reaction monitoring for quantitative analysis of phospholipids in plasma lipoproteins.在线微型非对称流场流分离 - 电喷雾电离 - 串联质谱法与选择反应监测用于定量分析血浆脂蛋白中的磷脂。
J Chromatogr A. 2014 Jan 10;1324:224-30. doi: 10.1016/j.chroma.2013.11.035. Epub 2013 Nov 22.
8
Phospholipids in lipoproteins: compositional differences across VLDL, LDL, and HDL in pregnant women.脂蛋白中的磷脂:孕妇的 VLDL、LDL 和 HDL 中的组成差异。
Lipids Health Dis. 2019 Jan 22;18(1):20. doi: 10.1186/s12944-019-0957-z.
9
Replication of LC-MS untargeted lipidomics results in patients with calcific coronary disease: An interlaboratory reproducibility study.钙化性冠心病患者液相色谱-质谱非靶向脂质组学结果的重复性研究:一项实验室间可重复性研究
Int J Cardiol. 2016 Nov 1;222:1042-1048. doi: 10.1016/j.ijcard.2016.07.214. Epub 2016 Aug 2.
10
Increases in dietary cholesterol and fat raise levels of apoprotein E-containing lipoproteins in the plasma of man.饮食中胆固醇和脂肪的增加会提高人体血浆中含载脂蛋白E的脂蛋白水平。
J Clin Endocrinol Metab. 1983 Jun;56(6):1108-15. doi: 10.1210/jcem-56-6-1108.

引用本文的文献

1
Apolipoprotein M expression modifies the sphingolipid landscape in murine blood and lymph.载脂蛋白M的表达改变了小鼠血液和淋巴中的鞘脂格局。
Front Immunol. 2025 May 2;16:1572959. doi: 10.3389/fimmu.2025.1572959. eCollection 2025.
2
Coronary artery disease is associated with particular change of serum metabolome: a case-control study.冠状动脉疾病与血清代谢组的特定变化相关:一项病例对照研究。
Metabolomics. 2025 Apr 26;21(3):57. doi: 10.1007/s11306-025-02253-z.
3
Towards Metabolomic-Based Precision Approaches for Classifying and Treating Heart Failure.

本文引用的文献

1
Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol.血浆神经酰胺可预测稳定型冠状动脉疾病和急性冠状动脉综合征患者的心血管死亡,且独立于低密度脂蛋白胆固醇。
Eur Heart J. 2016 Jul 1;37(25):1967-76. doi: 10.1093/eurheartj/ehw148. Epub 2016 Apr 28.
2
Sphingolipids Contribute to Human Atherosclerotic Plaque Inflammation.鞘脂类物质促成人类动脉粥样硬化斑块炎症。
Arterioscler Thromb Vasc Biol. 2016 Jun;36(6):1132-40. doi: 10.1161/ATVBAHA.116.305675. Epub 2016 Apr 7.
3
Metabolomic identification of a novel pathway of blood pressure regulation involving hexadecanedioate.
迈向基于代谢组学的心力衰竭分类与治疗精准方法
JACC Basic Transl Sci. 2024 Jul 31;9(9):1144-1158. doi: 10.1016/j.jacbts.2024.04.008. eCollection 2024 Sep.
4
Vascular lipidomics analysis reveales increased levels of phosphocholine and lysophosphocholine in atherosclerotic mice.血管脂质组学分析显示,动脉粥样硬化小鼠体内的磷酸胆碱和溶血磷酸胆碱水平升高。
Nutr Metab (Lond). 2023 Jan 4;20(1):1. doi: 10.1186/s12986-022-00723-y.
5
Genetic Architecture of Untargeted Lipidomics in Cardiometabolic-Disease Patients Combines Strong Polygenic Control and Pleiotropy.心血管代谢疾病患者非靶向脂质组学的遗传结构结合了强大的多基因控制和多效性。
Metabolites. 2022 Jun 27;12(7):596. doi: 10.3390/metabo12070596.
6
Non-targeted metabonomic analysis of plasma in patients with atherosclerosis by liquid chromatography-mass spectrometry.采用液相色谱-质谱联用技术对动脉粥样硬化患者血浆进行非靶向代谢组学分析。
Ann Transl Med. 2022 Feb;10(3):133. doi: 10.21037/atm-22-118.
7
Multi-Omics Prognostic Signatures Based on Lipid Metabolism for Colorectal Cancer.基于脂质代谢的结直肠癌多组学预后特征
Front Cell Dev Biol. 2022 Feb 11;9:811957. doi: 10.3389/fcell.2021.811957. eCollection 2021.
8
Examining the Interaction of the Gut Microbiome with Host Metabolism and Cardiometabolic Health in Metabolic Syndrome.探讨代谢综合征中肠道微生物组与宿主代谢及心血管代谢健康的相互作用。
Nutrients. 2021 Nov 29;13(12):4318. doi: 10.3390/nu13124318.
9
Volumetric Absorptive Microsampling of Blood for Untargeted Lipidomics.用于非靶向脂质组学的血液体积吸收微采样。
Molecules. 2021 Jan 7;26(2):262. doi: 10.3390/molecules26020262.
10
The Cardiac Lipidome in Models of Cardiovascular Disease.心血管疾病模型中的心脏脂质组
Metabolites. 2020 Jun 17;10(6):254. doi: 10.3390/metabo10060254.
代谢组学鉴定出一条涉及十六烷二酸的新型血压调节途径。
Hypertension. 2015 Aug;66(2):422-9. doi: 10.1161/HYPERTENSIONAHA.115.05544. Epub 2015 Jun 1.
4
Innovation in metabolomics to improve personalized healthcare.代谢组学的创新以改善个性化医疗。
Ann N Y Acad Sci. 2015 Jun;1346(1):57-62. doi: 10.1111/nyas.12775. Epub 2015 May 26.
5
Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis.神经酰胺作为非酒精性脂肪性肝病及相关动脉粥样硬化的介质。
PLoS One. 2015 May 20;10(5):e0126910. doi: 10.1371/journal.pone.0126910. eCollection 2015.
6
Urinary metabolic signatures of human adiposity.人类肥胖的尿液代谢特征。
Sci Transl Med. 2015 Apr 29;7(285):285ra62. doi: 10.1126/scitranslmed.aaa5680.
7
Molecular phenotyping of a UK population: defining the human serum metabolome.英国人群的分子表型分析:定义人类血清代谢组
Metabolomics. 2015;11(1):9-26. doi: 10.1007/s11306-014-0707-1. Epub 2014 Jul 25.
8
Biological functions of sphingomyelins.鞘磷脂的生物学功能。
Prog Lipid Res. 2013 Oct;52(4):424-37. doi: 10.1016/j.plipres.2013.05.001. Epub 2013 May 14.
9
The importance of experimental design and QC samples in large-scale and MS-driven untargeted metabolomic studies of humans.实验设计和质量控制样本在大规模、质谱驱动的人类非靶向代谢组学研究中的重要性。
Bioanalysis. 2012 Sep;4(18):2249-64. doi: 10.4155/bio.12.204.
10
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).《欧洲临床实践心血管疾病预防指南》(2012年版):欧洲心脏病学会及其他学会临床实践心血管疾病预防联合特别工作组(由九个学会的代表及特邀专家组成)。
Atherosclerosis. 2012 Jul;223(1):1-68. doi: 10.1016/j.atherosclerosis.2012.05.007. Epub 2012 May 14.